DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Wu D, Yang XO.
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2
inhibitor Fedratinib.
Journal of Microbiology, Immunology and Infection 2020;
53: 368-370
We do not assume any responsibility for the contents of the web pages of other providers.